Mist Pharmaceuticals is an emerging, specialty pharmaceutical company dedicated to improving the lives of patients. Mist’s commercialization of products that provide unique and meaningful clinical advantages improves the lives of patients who are suffering from ED and metabolic disease as well acute and chronic pain. Mist acquires under-promoted, under-utilized products and those in late stage clinical development, in order to enhance their market acceptance via reformulation or revitalized promotion. The end result is newer therapeutic options for providers and patients.